@Amateur_Inv That's all true. But while aduro sounds very promising, as far as I know, the cost-effectiveness of the whole process still hasn't been proven. And as great as the technology is, if it doesn't generate enough revenue in the end, even this amazing new chemical won't work.
@dmeinvestor When you're doing your analysis, could you also touch on the issue of cost-effectiveness? Has aduro made any statements yet about the cost-effectiveness of the entire process?
@ChrisMMillas I hope so too, but I actually thought it would go faster. All this good news about Maestro and everything else... but apparently it's not that simple
@bull_jared39128@RealSimpleAriel I'm going to try it with a small position. In a normal market, Poet should definitely drop, but things are crazy right now.
I think the same goes for Intel.
@PhathomResearch@maxfd95 Don't you think that also affects revenue? If everyone is just talking about Anthropic, maybe fewer companies will buy products from UiPath. I'm pretty sure that if the stock is getting a lot of attention, that can automatically lead to higher revenue. It's like free PR.